ImageWare Systems, Inc. (OTCQB: IWSY) is a leading developer of mobile and cloud-based identity management solutions, providing biometric authentication solutions for consumers and the enterprise. We deliver next-generation biometrics as an interactive and scalable cloud-based solution that brings together cloud and mobile technology; offering multi-factor authentication for smartphone users, mobile clients, and desktop devices.
As a pioneer and innovator in biometrics for decades, ImageWare reinvented the biometrics field with its algorithm-agnostic, real-time and ultra-scalable, patented IWS Biometric Engine®. We also offer credentialing and law enforcement technologies. Our product lines include: GoVerifyID Saas, GoVerifyID Enterprise Suite, GoMobile Interactive, GoCloudID, CloudID, pillphone, EPI Suite, EPI Builder, and Law Enforcement.
ImageWare has a diverse portfolio of technology products for enterprise, healthcare, retail, and financial industries as well as law enforcement and governmental agencies.
ImageWare holds 20 patents worldwide, with 14 pending, around multi-modal biometric technology. For additional information about our patents click the button below.
Rather than providing another front end biometric authentication modality like facial, iris or voice recognition, ImageWare dedicated its time and resources to building a back-end platform that would run millions of biometric searches at one time.Bruce Rogers, Chief Insights Officer, ForbesRead More at Forbes
Join the Conference Call
2017 Year-End Financial Results
Date: Monday, March 19, 2018
Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
International & Domestic: 1-778-327-3988
Beginning on March 19, 2018, at 7:30pm ET through March 26, 2018 at 11:59 pm ET, a replay of the recorded call will be available for 90 days. You can also listen to a replay of the call by dialing toll-free:
PIN Number: 10004429
Investor Quick Facts
Year end, December 31
Mayer Hoffman McCann P.C.
Computershare Trust Company
Bibicoff + MacInnis, Inc.
Disclosure Law Group
OTC Market Data